Skip to main content
. 2015 Feb 9;22(2):85–92. doi: 10.3727/096504014X14146137738547

Table 4.

Selected Agents Used in Elderly AML Patients

Agent Mechanism of Action
5-azacytidine (azacitidine), 5-aza-2′-deoxycytidine (decitabine) Inhibitors of DNA methylation
Gemtuzumab ozogamicin Recombinant anti-CD33 humanized antibody linked to N-acetyl-γ- calicheamicin
Clofarabine Second-generation purine nucleoside analog
Tipifarnib Farnesyltransferase inhibitor
Lestaurtinib FMS-like tyrosine kinase 3 (FLT-3) inhibitor
Sapacitabine Cytosine nucleoside analog